# Comparison of Cilotax Stent and Everolimus -Eluting Stent With Diabetes Mellitus (ESSENCE-DM III)

> **NCT01515228** · PHASE4 · COMPLETED · sponsor: **CHEOL WHAN LEE, MD, PhD.** · enrollment: 291 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Xience Prime
- **DEVICE:** Cilotax stent

## Key facts

- **NCT ID:** NCT01515228
- **Lead sponsor:** CHEOL WHAN LEE, MD, PhD.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2014-12
- **Final completion:** 2015-01
- **Target enrollment:** 291 (ACTUAL)
- **Last updated:** 2015-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01515228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01515228, "Comparison of Cilotax Stent and Everolimus -Eluting Stent With Diabetes Mellitus (ESSENCE-DM III)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01515228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*